THE INVENTION

THE INVENTION

sST2 as a therapeutic target for Alzheimer's disease

M: Medicine – Surgery – Orthopaedics – Material for disabled

THE INVENTION

Name of invention
sST2 as a therapeutic target for Alzheimer's disease

La sST2, cible thérapeutique pour la maladie d'Alzheimer

Invention description

Description
Discovery of sST2 as a causal factor of AD, its levels are positively associated with AD risk, particularly in ApoE4+ females, due to its inhibition of the normal IL33-ST2 signaling in microglia.


Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The show management declines all responsibility for any possible errors or omissions.